Literature DB >> 27582605

Epidemiology of Prostate and Testicular Cancer.

Pauline Filippou1, James E Ferguson1, Matthew E Nielsen1.   

Abstract

Prostate and testicular cancers account for a large percentage of cancer morbidity in men in the United States and worldwide due to high prevalence rates that continue to grow. Patterns of incidence and mortality vary greatly in both cancers among men of different age groups, ethnicities, and geographic locations. This article summarizes the incidence, prognosis, and risk factors of both prostate and testicular cancers, globally and in the United States.

Entities:  

Keywords:  epidemiology; interventional radiology; men's health; prostate cancer; testicular cancer

Year:  2016        PMID： 27582605      PMCID： PMC5005081          DOI： 10.1055/s-0036-1586146

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  16 in total

Review 1.  Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.

Authors:  Simon Evans; Chris Metcalfe; Fowzia Ibrahim; Raj Persad; Yoav Ben-Shlomo
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

2.  Effects of health insurance and race on early detection of cancer.

Authors:  R G Roetzheim; N Pal; C Tennant; L Voti; J Z Ayanian; A Schwabe; J P Krischer
Journal:  J Natl Cancer Inst       Date:  1999-08-18       Impact factor: 13.506

3.  Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

Authors:  Cindy Ke Zhou; David P Check; Joannie Lortet-Tieulent; Mathieu Laversanne; Ahmedin Jemal; Jacques Ferlay; Freddie Bray; Michael B Cook; Susan S Devesa
Journal:  Int J Cancer       Date:  2015-11-27       Impact factor: 7.396

4.  Race, socioeconomic status, and cause-specific mortality.

Authors:  G Howard; R T Anderson; G Russell; V J Howard; G L Burke
Journal:  Ann Epidemiol       Date:  2000-05       Impact factor: 3.797

5.  Mendelian inheritance of familial prostate cancer.

Authors:  B S Carter; T H Beaty; G D Steinberg; B Childs; P C Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

6.  Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.

Authors:  J Beilin; E M Ball; J M Favaloro; J D Zajac
Journal:  J Mol Endocrinol       Date:  2000-08       Impact factor: 5.098

7.  Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data.

Authors:  Charlotte Le Cornet; Joannie Lortet-Tieulent; David Forman; Rémi Béranger; Aude Flechon; Béatrice Fervers; Joachim Schüz; Freddie Bray
Journal:  Eur J Cancer       Date:  2013-12-23       Impact factor: 9.162

8.  Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?

Authors:  Gary D Grossfeld; David M Latini; Tracy Downs; Deborah P Lubeck; Shilpa S Mehta; Peter R Carroll
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

Review 9.  Site-specific familial aggregation of prostate cancer.

Authors:  Bas A J Verhage; Katja K H Aben; J Alfred Witjes; Huub Straatman; Jack A Schalken; Lambertus A L M Kiemeney
Journal:  Int J Cancer       Date:  2004-04-20       Impact factor: 7.396

Review 10.  Epidemiology and Diagnosis of Testis Cancer.

Authors:  Scott M Stevenson; William T Lowrance
Journal:  Urol Clin North Am       Date:  2015-06-11       Impact factor: 2.241
View more
  8 in total

1.  The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.

Authors:  Henrique J Cardoso; Marília I Figueira; Sílvia Socorro
Journal:  J Cell Commun Signal       Date:  2017-06-27       Impact factor: 5.782

2.  Identification of a serum biomarker signature associated with metastatic prostate cancer.

Authors:  Venera Kuci Emruli; Leena Liljedahl; Ulrika Axelsson; Corinna Richter; Lisa Theorin; Anders Bjartell; Hans Lilja; Jenny Donovan; David Neal; Freddie C Hamdy; Carl A K Borrebaeck
Journal:  Proteomics Clin Appl       Date:  2021-05-04       Impact factor: 3.603

3.  Evolution of the Histo-Epidemiological Profile of Urological Cancers in Togo

Authors:  Tchin Darré; Koué Folligan; Tchilabalo Matchonna Kpatcha; Kokou Kanassoua; Edoe Sewa; Sassil Daré; Kodjo Tengue; Koffi Amégbor; Gado Napo Koura
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

4.  Incidence and Survival for Common Cancers Are Lower in New Mexico and Along the US-Mexico Border Than Elsewhere in the United States.

Authors:  Zachariah Taylor; Kayla Chory; Mark Wright; Anup Amatya; Charlotte Gard; Michael E Woods
Journal:  Cureus       Date:  2020-10-29

Review 5.  STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors.

Authors:  Maciej Golus; Piotr Bugajski; Joanna Chorbińska; Wojciech Krajewski; Artur Lemiński; Jolanta Saczko; Julita Kulbacka; Tomasz Szydełko; Bartosz Małkiewicz
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

6.  Tunica vaginalis testis metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report.

Authors:  Yong-Rui Zhang; Dong-Kai Ma; Bao-Shan Gao; Wei An; Kai-Min Guo
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

Review 7.  Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far?

Authors:  Pedro Leonel Almeida; Bruno Jorge Pereira
Journal:  Prostate Cancer       Date:  2018-03-19

8.  Dataset of testicular germ cell tumors (TGCT) risk associated with serum polychlorinated biphenyl (PCB) by age at diagnosis and histologic types.

Authors:  Zhiyuan Cheng; Xichi Zhang; Bryan Bassig; Russ Hauser; Theodore R Holford; Elizabeth Zheng; Dian Shi; Yong Zhu; Stephen Marc Schwartz; Chu Chen; Kunchong Shi; Bo Yang; Zhengmin Qian; Peter Boyle; Tongzhang Zheng
Journal:  Data Brief       Date:  2021-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.